Real-time enrollment status for this clonal hematopoiesis of indeterminate potential clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 1:27 AM UTC
| NCT Number | NCT04102423 |
| Recruiting Status | Recruiting |
| Condition | Clonal Hematopoiesis of Indeterminate Potential |
| Phase | Clinical Trial |
| Target Enrollment | 306 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Heart, Lung, and Blood Institute (NHLBI) |
| Last Updated on CT.gov | August 21, 2026 (1 week ago) |
As of September 1, 2026: Clinical trial NCT04102423 is currently recruiting participants. This clinical trial study for clonal hematopoiesis of indeterminate potential is actively seeking new participants at 1 location across the United States. The study is sponsored by National Heart, Lung, and Blood Institute (NHLBI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04102423 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04102423 was last updated 1 week ago (August 21, 2026). HelloStudys verifies this status automatically.